Impact of sex on short term in-hospital outcomes with transcatheter edge-to-edge mitral valve repair

Cardiovascular Revascularization Medicine

Volumn 19, Issue 2, 2018, Pages 182-185

  Doshi, Rajkumar ^a   Shlofmitz, Evan ^a   Vadher, Abhishek ^a   Shah, Jay ^a   Meraj, Perwaiz ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Mitral regurgitation; Short term in hospital outcomes; Transcatheter mitral valve repair

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BLEEDING; CARDIAC PATIENT; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; CHARLSON COMORBIDITY INDEX; COMORBIDITY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE ACCESS; HEALTH DISPARITY; HOSPITAL MORTALITY; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; ICD-9-CM; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX; SMOKING; SURGICAL PATIENT; TRANSCATHETER EDGE TO EDGE MITRAL VALVE REPAIR; COMPARATIVE STUDY; CONVALESCENCE; DEVICES; DIAGNOSTIC IMAGING; FACTUAL DATABASE; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; HOSPITAL COST; MIDDLE AGED; MITRAL VALVE; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX FACTOR; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIAC CATHETERIZATION; DATABASES, FACTUAL; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 85026836917     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2017.07.002     Document Type: Article

References (27)

1. Enriquez-Sarano, M., Akins, C.W., Vahanian, A., Mitral regurgitation. Lancet 373:9672 (2009), 1382–1394.
2. Iung, B., Baron, G., Butchart, E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease. Eur Heart J 24:13 (2003), 1231–1243.
3. Nkomo, V.T., Gardin, J.M., Skelton, T.N., Gottdiener, J.S., Scott, C.G., Enriquez-Sarano, M., Burden of valvular heart diseases: a population-based study. Lancet 368:9540 (2006), 1005–1011.
4. Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg 148:1 (2014), e1–e132.
5. Mauri, L., Foster, E., Glower, D.D., et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol 62:4 (2013), 317–328.
6. Mirabel, M., Iung, B., Baron, G., et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J 28:11 (2007), 1358–1365.
7. Haan, C.K., Cabral, C.I., Conetta, D.A., Coombs, L.P., Edwards, F.H., Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg 78:3 (2004), 820–825.
8. Tribouilloy, C.M., Enriquez-Sarano, M., Schaff, H.V., et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 99:3 (1999), 400–405.
9. Vassileva, C.M., McNeely, C., Mishkel, G., Boley, T., Markwell, S., Hazelrigg, S., Gender differences in long-term survival of Medicare beneficiaries undergoing mitral valve operations. Ann Thorac Surg 96:4 (2013), 1367–1373.
10. McNeely, C., Vassileva, C., Mitral valve surgery in women: another target for eradicating sex inequality. Circ Cardiovasc Qual Outcomes 9:2 Suppl 1 (2016), S94–S96.
11. Mokhles, M.M., Siregar, S., Versteegh, M.I., et al. Male-female differences and survival in patients undergoing isolated mitral valve surgery: a nationwide cohort study in the Netherlands. Eur J Cardiothorac Surg 50:3 (2016), 482–487.
12. Seeburger, J., Eifert, S., Pfannmuller, B., et al. Gender differences in mitral valve surgery. Thorac Cardiovasc Surg 61:1 (2013), 42–46.
13. Gafoor, S., Sievert, H., Maisano, F., et al. Gender in the ACCESS-EU registry: a prospective, multicentre, non-randomised post-market approval study of MitraClip(R) therapy in Europe. EuroIntervention 12:2 (2016), e257–e264.
14. Tigges, E., Kalbacher, D., Thomas, C., et al. Transcatheter mitral valve repair in surgical high-risk patients: gender-specific acute and long-term outcomes. Biomed Res Int, 2016, 2016, 3934842.
15. Estevez-Loureiro, R., Settergren, M., Winter, R., et al. Effect of gender on results of percutaneous edge-to-edge mitral valve repair with MitraClip system. Am J Cardiol 116:2 (2015), 275–279.
16. Feldman, T., Kar, S., Rinaldi, M., et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (endovascular valve edge-to-edge REpair study) cohort. J Am Coll Cardiol 54:8 (2009), 686–694.
17. HCUP National Inpatient Sample (NIS), Healthcare cost and utilization project (HCUP). 2012, Agency for Healthcare Research and Quality R, MD.
18. Deshmukh, A., Patel, N.J., Pant, S., et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation 128:19 (2013), 2104–2112.
19. Elixhauser, A., Steiner, C., Harris, D.R., Coffey, R.M., Comorbidity measures for use with administrative data. Med Care 36:1 (1998), 8–27.
20. Austin, S.R., Wong, Y.N., Uzzo, R.G., Beck, J.R., Egleston, B.L., Why summary comorbidity measures such as the Charlson comorbidity index and Elixhauser score work. Med Care 53:9 (2015), e65–e72.
21. Tamburino, C., Ussia, G.P., Maisano, F., et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 31:11 (2010), 1382–1389.
22. Surder, D., Pedrazzini, G., Gaemperli, O., et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart 99:14 (2013), 1034–1040.
23. Ledwoch, J., Bertog, S., Wunderlich, N., et al. Predictors for prolonged hospital stay after transcatheter mitral valve repair with the MitraClip. Catheter Cardiovasc Interv 84:4 (2014), 599–605.
24. Paranskaya, L., D'Ancona, G., Bozdag-Turan, I., et al. Residual mitral valve regurgitation after percutaneous mitral valve repair with the MitraClip(R) system is a risk factor for adverse one-year outcome. Catheter Cardiovasc Interv 81:4 (2013), 609–617.
25. Wan, B., Rahnavardi, M., Tian, D.H., et al. A meta-analysis of MitraClip system versus surgery for treatment of severe mitral regurgitation. Ann Cardiothorac Surg 2:6 (2013), 683–692.
26. Feldman, T., Foster, E., Glower, D.D., et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:15 (2011), 1395–1406.
27. Attizzani, G.F., Ohno, Y., Capodanno, D., et al. Gender-related clinical and echocardiographic outcomes at 30-day and 12-month follow up after MitraClip implantation in the GRASP registry. Catheter Cardiovasc Interv 85:5 (2015), 889–897.